Richard Foemmel

Richard Foemmel is a seasoned professional with a diverse background, well-versed in serving on non-profit and biotech company boards, consulting for early-stage biomedical companies, and assuming roles as an interim CEO for university-based start-ups.

His educational journey includes obtaining an MBA in Business from NYU Stern School of Business, a PhD in Biochemistry from the University of Michigan Medical School, and a B.A. in Chemistry from Cornell College.

Throughout his career, Richard has held various prominent positions in both non-profit and corporate sectors, including Chairman of the Board of Trustees at Rivier University, President of the Board of Trustees at Nashua Symphony Association, Interim CEO at AgaMatrix, President & CEO at DecImmune Therapeutics, President & CEO at CytoLogix Corp, Vice President at Dianon Systems, and Research Director at Abbott Diagnostics.